N. Mumbai, India

Sachin Srivastava


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • N. Mumbai, IN (2016 - 2017)
  • Navi Mumbai, IN (2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Profile: Sachin Srivastava

Introduction: Sachin Srivastava is a prominent inventor based in Navi Mumbai, India, known for his contributions to pharmaceutical innovations. With a commendable portfolio of five patents, Srivastava has made significant strides in the development of novel compounds, particularly in the field of diabetes management.

Latest Patents: Among his latest innovations, Srivastava has developed a process for the preparation of canagliflozin, an important medication used to treat type 2 diabetes. This patent focuses on the efficient synthesis of canagliflozin and its intermediates. Additionally, he has been working on a process for the preparation of dipeptidylpeptidase inhibitors, specifically linagliptin. This complex process involves the deprotection of compounds to form the desired pharmaceutical agents, ensuring a methodical approach to drug formulation.

Career Highlights: Currently employed at Glenmark Pharmaceuticals Limited, Srivastava's work centers around advancing therapeutic solutions that benefit patients globally. His innovative mindset and dedication to research have positioned him as a key player in the pharmaceutical industry.

Collaborations: Throughout his career, Sachin has collaborated with talented individuals such as Shekhar Bhaskar Bhirud and Samir Naik. Their combined expertise fosters an environment of creativity and progress, leading to impactful inventions within their field.

Conclusion: Sachin Srivastava exemplifies the spirit of innovation through his patents and contributions to the pharmaceutical sector. His relentless pursuit of better treatment options and methodologies continues to inspire colleagues and emerging inventors alike, solidifying his status as a distinguished inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…